Logo
Login
$GTX
$21.69 +$0.14 (0.65%) Close

Company Executives

$GTX Management Team

Mr. Daniel Ninivaggi

Independent Chairman of the Board

Age 59
Compensation $347.5K USD
Sex Male

Mr. Olivier Rabiller

President

Chief Executive Officer

Director

Age 54
Compensation $8.664M USD
Sex Male

Mr. Sean Deason

Chief Financial Officer

Senior Vice President

Age 53
Compensation $3.175M USD
Sex Male

Mr. Fabrice Spenninck

Chief Human Resources Officer

Senior Vice President

Age 56
Compensation -
Sex Male

Mr. Craig Balis

Senior Vice President

Chief Technology Officer

Age 60
Compensation $2.312M USD
Sex Male

Mr. Daniel Deiro

Senior Vice President - Global Customer Management

General Manager

Japan/Korea

Age 52
Compensation $955.7K USD
Sex Male

Mr. Pierre Barthelet

Senior Vice President - Strategy

Business Development & Advanced Technologies

Age 59
Compensation -
Sex Male

Mr. Thierry Mabru

Senior Vice President - Integrated Supply Chain

Age 57
Compensation $2.264M USD
Sex Male

Ms. Joanne Lau

Chief Accounting Officer

Vice President

Corporate Controller

Age 48
Compensation -
Sex Female

Mr. Eric Birge

Investor Relations

Age -
Compensation -
Sex Male

Mr. Cyril Grandjean

IR Contact Officer

Age -
Compensation -
Sex Male

Board of Directors

From the proxy statement filed Apr 10, 2026
Directors
8
serving now
Independent
6 of 6
stated in the proxy; 2 not stated
Average tenure
4.6 years
from year joined
CEO also chairs the board
No
Daniel Ninivaggi
Director Age On board Independent Committees Other public boards 2025 pay Source
Daniel Ninivaggi
Board chair
 61 2021
5 years
 Independent
Technology & Innovation Committee
Indivior Pharmaceuticals Inc., a specialty pharmaceuticals company, since January 2025 $404,459
Paul Camuti
64 2024
2 years
 Independent
Nominating & Governance Committee · Chair
None stated $269,570
Joachim Drees
61 2024
2 years
 Independent
Audit Committee
None stated $275,123
D’Aun Norman
59 2021
5 years
 Independent
Audit Committee · Chair
PHINIA Inc. (NYSE: PHIN) $276,650
Olivier Rabiller
CEO
 55 2018
8 years
 Not stated
Technology & Innovation Committee
None stated Paid as CEO
Julia Steyn
50 2021
5 years
 Independent
Technology & Innovation Committee
None stated $275,428
Steven Tesoriere
48 2021
5 years
 Independent
Talent Management & Compensation Committee
None stated Not stated
Robert Shanks Leaving at the meeting
Not stated Not stated Not stated None stated None stated $273,354
Nominated to join at the meeting
Not on the board yet; they join only if elected.

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

2 disclosed in the proxy filed Apr 10, 2026
Oaktree
Oaktree and its affiliates beneficially own in excess of 5% of our outstanding common stock
Amount not stated
2025

Company repurchased 5,000,000 shares of common stock from Oaktree-affiliated funds at $12.42 per share on August 20, 2025.

With funds affiliated with Oaktree Open in proxy
Oaktree
Oaktree and its affiliates beneficially own in excess of 5% of our outstanding common stock
Amount not stated
2025

Company repurchased 2,500,000 shares of common stock from Oaktree-affiliated funds at $16.26 per share on November 3, 2025.

With funds affiliated with Oaktree Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans